Cargando…

Analytical and Clinical Performance of a Real-time Screening PCR Assay Identifying Congenital CMV Infection

BACKGROUND: Congenital CMV infection (cCMV) is the most common identifiable cause of mental retardation in the United States but requires early diagnosis to define the infection and to institute effective antiviral therapy. Traditional identification strategies including hearing screens and physical...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohde, Benjamin, Carillo-Marquez, Maria, Tomlinson, Ryan, Blanch, Jacqueline, Kim-Hoehamer, Young-In, Patel, Hema, Patel, Chirag, Zanalian, Gita, Osborne, Gertrude, Davis, Joseph, Patel, Anami, Devincenzo, John P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631887/
http://dx.doi.org/10.1093/ofid/ofx163.861
_version_ 1783269583279357952
author Rohde, Benjamin
Carillo-Marquez, Maria
Tomlinson, Ryan
Blanch, Jacqueline
Kim-Hoehamer, Young-In
Patel, Hema
Patel, Chirag
Zanalian, Gita
Osborne, Gertrude
Davis, Joseph
Patel, Anami
Devincenzo, John P
author_facet Rohde, Benjamin
Carillo-Marquez, Maria
Tomlinson, Ryan
Blanch, Jacqueline
Kim-Hoehamer, Young-In
Patel, Hema
Patel, Chirag
Zanalian, Gita
Osborne, Gertrude
Davis, Joseph
Patel, Anami
Devincenzo, John P
author_sort Rohde, Benjamin
collection PubMed
description BACKGROUND: Congenital CMV infection (cCMV) is the most common identifiable cause of mental retardation in the United States but requires early diagnosis to define the infection and to institute effective antiviral therapy. Traditional identification strategies including hearing screens and physical exams likely miss many patients with cCMV. We therefore developed and evaluated the performance of a PCR assay optimized for low cost, specimen collection at time of dried blood spot collection, and detection thresholds below the salivary CMV concentrations known to occur in cCMV patients. METHODS: We utilized a real-time CMV PCR assay (Simplexa(TM) CMV)(DiaSorin, Cypress CA) amplifying the UL83 gene and the 3M Integrated Cycler. Saliva was collected from volunteers (Copan swab), and spiked with known concentrations of CMV culture supernatant quantified by COBAS Ampliprep(TM). (Roche Diagnostics). Additionally, saliva was collected by copan swab from all births within a single multi-hospital system from 3/21/16 – 5/4/17. Newborns who were initial screen PCR positive were subsequently evaluated by urine CMV PCR by an outside laboratory for confirmation of cCMV. RESULTS: Analytical threshold of detection was well below 4 log copies/ML, with 100% of samples testing positive at 3.5 log copies/ML (Fig 1). 6127 newborn saliva samples were evaluated and 61 were PCR positive (£40 CT). 47 of these tests were confirmed by urine PCR (Fig 2) (PPV 0.9792, NPV 0.9988, Sens 0.8704, Spec 0.9998). Screen positive tests which were not confirmed by urine PCR had CT values £36. Adjusting the definition of a positive to CT £36 further improved the performance (PPV >0.9999, NPV 0.9997, Sens 0.9592, Spec >0.9999). CONCLUSION: We demonstrate good performance of a congenital CMV methodology thus facilitating an effective universal newborn screening program DISCLOSURES: J. P. Devincenzo, AstraZeneca/MedImmune: Investigator, Research support
format Online
Article
Text
id pubmed-5631887
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56318872017-11-07 Analytical and Clinical Performance of a Real-time Screening PCR Assay Identifying Congenital CMV Infection Rohde, Benjamin Carillo-Marquez, Maria Tomlinson, Ryan Blanch, Jacqueline Kim-Hoehamer, Young-In Patel, Hema Patel, Chirag Zanalian, Gita Osborne, Gertrude Davis, Joseph Patel, Anami Devincenzo, John P Open Forum Infect Dis Abstracts BACKGROUND: Congenital CMV infection (cCMV) is the most common identifiable cause of mental retardation in the United States but requires early diagnosis to define the infection and to institute effective antiviral therapy. Traditional identification strategies including hearing screens and physical exams likely miss many patients with cCMV. We therefore developed and evaluated the performance of a PCR assay optimized for low cost, specimen collection at time of dried blood spot collection, and detection thresholds below the salivary CMV concentrations known to occur in cCMV patients. METHODS: We utilized a real-time CMV PCR assay (Simplexa(TM) CMV)(DiaSorin, Cypress CA) amplifying the UL83 gene and the 3M Integrated Cycler. Saliva was collected from volunteers (Copan swab), and spiked with known concentrations of CMV culture supernatant quantified by COBAS Ampliprep(TM). (Roche Diagnostics). Additionally, saliva was collected by copan swab from all births within a single multi-hospital system from 3/21/16 – 5/4/17. Newborns who were initial screen PCR positive were subsequently evaluated by urine CMV PCR by an outside laboratory for confirmation of cCMV. RESULTS: Analytical threshold of detection was well below 4 log copies/ML, with 100% of samples testing positive at 3.5 log copies/ML (Fig 1). 6127 newborn saliva samples were evaluated and 61 were PCR positive (£40 CT). 47 of these tests were confirmed by urine PCR (Fig 2) (PPV 0.9792, NPV 0.9988, Sens 0.8704, Spec 0.9998). Screen positive tests which were not confirmed by urine PCR had CT values £36. Adjusting the definition of a positive to CT £36 further improved the performance (PPV >0.9999, NPV 0.9997, Sens 0.9592, Spec >0.9999). CONCLUSION: We demonstrate good performance of a congenital CMV methodology thus facilitating an effective universal newborn screening program DISCLOSURES: J. P. Devincenzo, AstraZeneca/MedImmune: Investigator, Research support Oxford University Press 2017-10-04 /pmc/articles/PMC5631887/ http://dx.doi.org/10.1093/ofid/ofx163.861 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Rohde, Benjamin
Carillo-Marquez, Maria
Tomlinson, Ryan
Blanch, Jacqueline
Kim-Hoehamer, Young-In
Patel, Hema
Patel, Chirag
Zanalian, Gita
Osborne, Gertrude
Davis, Joseph
Patel, Anami
Devincenzo, John P
Analytical and Clinical Performance of a Real-time Screening PCR Assay Identifying Congenital CMV Infection
title Analytical and Clinical Performance of a Real-time Screening PCR Assay Identifying Congenital CMV Infection
title_full Analytical and Clinical Performance of a Real-time Screening PCR Assay Identifying Congenital CMV Infection
title_fullStr Analytical and Clinical Performance of a Real-time Screening PCR Assay Identifying Congenital CMV Infection
title_full_unstemmed Analytical and Clinical Performance of a Real-time Screening PCR Assay Identifying Congenital CMV Infection
title_short Analytical and Clinical Performance of a Real-time Screening PCR Assay Identifying Congenital CMV Infection
title_sort analytical and clinical performance of a real-time screening pcr assay identifying congenital cmv infection
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631887/
http://dx.doi.org/10.1093/ofid/ofx163.861
work_keys_str_mv AT rohdebenjamin analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT carillomarquezmaria analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT tomlinsonryan analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT blanchjacqueline analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT kimhoehameryoungin analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT patelhema analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT patelchirag analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT zanaliangita analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT osbornegertrude analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT davisjoseph analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT patelanami analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection
AT devincenzojohnp analyticalandclinicalperformanceofarealtimescreeningpcrassayidentifyingcongenitalcmvinfection